Cangrelor tetrasodium
{[allProObj[0].p_purity_real_show]}
货号：A605340
同义名：
AR-C69931MX tetrasodium;Cangrelor (sodium salt)
Cangrelor is a potent and competitive P2Y12 receptor inhibitor that inhibits of ADP-induced platelet aggregation.
Cangrelor tetrasodium 化学结构
Cangrelor tetrasodium 3D分子结构
规格
价格
会员价
库存
数量
{[ item.pr_size ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}
{[ getRatePrice(item.pr_rmb_sale, 1,1) ]}
{[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}
{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]}
{[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb_sale, 1,1) ]}
{[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]}
{[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]}
现货
咨询
-
+
Cangrelor tetrasodium 纯度/质量文件 产品仅供科研
货号：A605340
标准纯度：
{[allProObj[0].p_purity_real_show]}
产品说明书
全球学术期刊中引用的产品
• Nat. Biomed. Eng. , 2024, 8, 1412-1424. Ambeed. A538667 ,
A631746
]
• JMC , 2024. Ambeed. A356070
]
• BMC Cancer , 2024, 24(1): 1415. Ambeed. A209020
]
• J. Am. Soc. Mass Spectrom. , 2024, 35(12): 3192-3202. Ambeed. A961334 ,
A292945 ,
A230770 ,
A300620 ,
A1114580 ,
A1159765 ,
A206238
]
• PloS One , 2024, 19(11): e0308060. Ambeed. 更多 >
Cangrelor tetrasodium 质控信息
Cangrelor tetrasodium 生物活性
靶点
描述
Cangrelor is the only currently available intravenous platelet P2Y12 receptor inhibitor, and its quick onset and offset make it an appealing option for antiplatelet therapy[1] [2] [3]
Cangrelor tetrasodium 临床研究
NCT号
适应症或疾病
临床期
招募状态
预计完成时间
地点
NCT03182855
Acute Coronary Syndrome
... 展开 >> Myocardial Infarction
STEMI - ST Elevation Myocardial Infarction 收起 <<
Phase 4
Not yet recruiting
August 1, 2019
Denmark
... 展开 >> Aarhus University Hospital
Not yet recruiting
Aarhus, Denmark, 8200
Contact: Jacob Thorsted Sorensen, MD, PhD +4540143563 jacsoe@rm.dk
Contact: Steen D Kristensen, MD, DMSc +4530922336 stekrist@rm.dk 收起 <<
Cangrelor tetrasodium 参考文献
[1] De Luca L, Steg PG, Bhatt DL, Capodanno D, Angiolillo DJ. Cangrelor: Clinical Data, Contemporary Use, and Future Perspectives. J Am Heart Assoc. 2021;10(13):e022125.
[2] Kassassir H, Siewiera K, Sychowski R, Watała C. Can the antiplatelet effects of cangrelor be reliably studied in mice under in vivo and in vitro conditions using flow cytometry?. Pharmacol Rep. 2013;65(4):870-883.
[3] Zhan T, Wei T, Dong L, et al. Cangrelor alleviates bleomycin-induced pulmonary fibrosis by inhibiting platelet activation in mice. Mol Immunol. 2020;120:83-92.
Cangrelor tetrasodium 实验方案
计算器
摩尔计算器
总药量计算器
工作液计算器
存储液制备
1mg
5mg
10mg
1 mM
5 mM
10 mM
1.16mL
0.23mL
0.12mL
5.79mL
1.16mL
0.58mL
11.57mL
2.31mL
1.16mL
Cangrelor tetrasodium 技术信息
搜索
